CCL2 and Sepsis: Notably, our analyses revealed dynamic CCL2 upregulation in PLF during early sepsis, which was substantially attenuated by rIGFBP6 administration (Figure 6A), with minimal alterations observed in other cytokines/chemokines (Supplemental Figures 9 and 10).